华登氏巨球蛋白血症
巨球蛋白血症
淋巴增殖性病變
疾病
骨髓
三体
抗体
医学
淋巴瘤
免疫球蛋白M
免疫学
单克隆
病理
单克隆抗体
生物
多发性骨髓瘤
免疫球蛋白G
遗传学
作者
Sabina Ševčı́ková,Lea Novak,Lenka Kubiczková,Elena Dementyeva,Lucie Říhová,Roman Hájek
出处
期刊:PubMed
日期:2012-01-01
卷期号:25 (6): 413-20
摘要
Waldenström macroglobulinemia is a rare lymphoproliferative disease that is currently classified into lymphomas with incidence of 3 cases per million. This disease comprises about 1-2% of hematological malignancies and is characterized by infiltration of malignant B cells into the bone marrow and presence of monoclonal immunoglobulin IgM in serum. WM is still an incurable disease with median survival of 5 years. Molecular basis of this disease remains unclear even though deletion of 6q, trisomy of chromosomes 4 and 8, deletion of 13q and increased expression of IL-6 seem to be typical for this disease. The most important changes of microRNA are increased expression of miR-155 and decreased expression of miR-9*. This work aims to describe current knowledge about the molecular basis of this disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI